Christopher C. Chapman's most recent trade in Mira Pharmaceuticals Inc was a trade of 50,000 Stock Options done . Disclosure was reported to the exchange on Aug. 17, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mira Pharmaceuticals Inc | Christopher C. Chapman | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 50,000 | 50,000 | - | - | Stock Options | |
| TNF Pharmaceuticals Inc. | Christopher C. Chapman | Director, President, Chief Med. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 300,000 | 300,000 | - | - | Employee Stock Option (Right to Buy) | |
| TNF Pharmaceuticals Inc. | Christopher C. Chapman | Director, President, Chief Med. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 750,000 | 750,000 | - | - | Employee Stock Option (Right to Buy) |